290650.KQ L&C Bio Co., Ltd
KOEHealthcareAs of 2026-08-09 03:20
Why 290650.KQ matters now
L&C Bio Co., Ltd (290650.KQ) is a Korea stock in Healthcare. The latest InvestLog snapshot shows ₩62,000.00 with -2.82% on the session and ₩1.67T in market capitalization.
Valuation context is available even where detailed statement rows are sparse: InvestLog currently shows P/E -10.81, gross margin 54.6%, and operating margin 10.8%.
Valuation
P/E (TTM)
-10.81
PEG
—
P/B
7.95
P/S
15.56
EV/EBITDA
90.78
DCF Value
—
FCF Yield
-0.2%
Div Yield
0.1%
Margins & Returns
Gross Margin
54.6%
Operating Margin
10.8%
Net Margin
-137.8%
ROE
-55.7%
ROA
-28.9%
ROIC
3.0%
Listing Info
Market
Korea
Exchange
KOE
Currency
KRW
Sector
Healthcare
Industry
Medical - Devices
Country
KR
Specializing in regenerative tissue medicine, L&C BIO Co., Ltd. operates as a dedicated research and development enterprise. The company's diverse product range encompasses human tissue products, various medical devices, and a selection of cosmetic solutions. Established in 2011, this firm is headquartered in Seongnam, South Korea.